HayderSBjorkONilssonB. Relapse factors during maintenance therapy of acute lymphoblastic leukemia in children. Pediatr Hematol Oncol1992; 9: 21–27.
2.
KumarSDixitRKarmakarSet al.Unusual nail pigmentation following cyclophosphamide-containing chemotherapy regimen. Indian J Pharmacol2010; 42: 243–244.
3.
LopesMJordaoCGrynszpanRet al.Chromonychia secondary to chemotherapy. Case Rep Dermatol2013; 5: 163–167.
4.
VukeljaSJBonnerMWMcColloughMet al.Unusual serpentine hyperpigmentation associated with 5-fluorouracil. Case report and review of cutaneous manifestations associated with systemic 5-fluorouracil. J Am Acad Dermatol1991; 25: 905–908.
5.
RaischDWCampbellWGargVet al.Description of anaphylactic reactions to paclitaxel and docetaxel reported to the FDA, with a focus on the role of premedication. Expert Opin Drug Saf2011; 10: 521–528.
ReiterASchrappeMLudwigWDet al.Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group. Blood1992; 80: 2471–2478.
8.
DasariPSagiliH. Life-threatening complications following multidose methotrexate for medical management of ectopic pregnancy. BMJ Case Rep2012; 2012: bcr0320126023. doi: 10.1136/bcr-03-2012-6023.
9.
van den BosCBieringsMBBruinMCet al.Cutaneous side effects of medium dose methotrexate in children with acute lymphoblastic leukaemia. Med Pediatr Oncol2000; 34: 278–280.
10.
Saez-AyalaMMontenegroMFSanchez-Del-CampoLet al.Directed phenotype switching as an effective antimelanoma strategy. Cancer Cell2013; 24: 105–119.
